CSPCY (CSPC Pharmaceutical Group) Accumulated Depreciation: $-1,040 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSPCY CSPC Pharmaceutical Group Ltd CSPCY
80 GF Score
Price $4.39
GF Value $5.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Accumulated Depreciation?

CSPC Pharmaceutical Group CSPCY -2.88% 80 Accumulated Depreciation is $-1,040 Mil as of Dec. 2025. GuruFocus rates CSPCY with a GF Score™ of 80/100 and a GF Value™ of $5.22 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

CSPC Pharmaceutical Group's quarterly accumulated depreciation increased from Dec. 2024 ($-872 Mil) to Jun. 2025 ($-949 Mil) and increased from Jun. 2025 ($-949 Mil) to Dec. 2025 ($-1,040 Mil).

CSPC Pharmaceutical Group's annual accumulated depreciation increased from Dec. 2023 ($-763 Mil) to Dec. 2024 ($-872 Mil) and increased from Dec. 2024 ($-872 Mil) to Dec. 2025 ($-1,040 Mil).

CSPC Pharmaceutical Group Accumulated Depreciation Related Terms

CSPC Pharmaceutical Group Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Accumulated Depreciation Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -606.07 -664.49 -763.12 -872.44 -1,040.22

CSPC Pharmaceutical Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -794.92 -872.44 -948.50 -1,040.22 0.00
CSPCY
80GF Score
CSPC Pharmaceutical Group Ltd CSPCY
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-1,040 Mil mean?
CSPC Pharmaceutical Group (CSPCY) has a Accumulated Depreciation of $-1,040 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's Accumulated Depreciation too high?
CSPC Pharmaceutical Group's current Accumulated Depreciation is $-1,040 Mil. Overall, CSPC Pharmaceutical Group has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Accumulated Depreciation compare to LLY and JNJ?
CSPC Pharmaceutical Group's Accumulated Depreciation of $-1,040 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current Accumulated Depreciation is $-1,040 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.22, compared to a current price of $4.39 — trading 15.9% below its estimated fair value. The current Accumulated Depreciation is $-1,040 Mil. CSPC Pharmaceutical Group's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Accumulated Depreciation is $-1,040 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be undervalued. The current stock price of $4.39 is trading 15.9% below its estimated GF Value™ of $5.22. GuruFocus considers CSPC Pharmaceutical Group to be Modestly Undervalued.

Key valuation signals for CSPCY:

  • Accumulated Depreciation: $-1,040 Mil
  • GF Value™: $5.22 vs. price of $4.39 (15.9% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
80GF Score

Get the complete analysis for CSPCY

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.39
Price
$5.22
GF Value